Article Details
Retrieved on: 2025-02-03 16:41:59
Tags for this article:
Click the tags to see associated articles and topics
Summary
Beacon Therapeutics' gene therapy for retinitis pigmentosa, aiming to treat photoreceptor damage, received FDA's Regenerative Medicine Advanced Therapy designation. This reflects its potential for addressing unmet medical needs and accelerating development through FDA guidance.
Article found on: www.modernretina.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here